{"schema_version":"secwatch.filing_event.v1","accession":"0001854270-23-000079","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.266204+00:00","generated_at":"2026-06-13T18:27:09.434450+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Senti Biosciences stockholders elect three Class I directors and ratify KPMG at 2023 annual meeting","bullets":["Timothy Lu, M.D., Ph.D. elected with 32.3M votes for; Edward Mathers elected with 22.5M for; Omid Farokhzad, M.D. elected with 26.2M for.","KPMG LLP ratified as independent auditor for fiscal 2023 with 34.4M votes for, 60,890 against, 54,266 abstain.","Meeting held June 16, 2023; 34.5M shares represented (78.0% of outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001854270-23-000079","json":"https://secwatch.observer/filing/0001854270-23-000079.json","markdown":"https://secwatch.observer/filing/0001854270-23-000079.md","text":"https://secwatch.observer/filing/0001854270-23-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/snti-20230616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T18:27:09.434450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"46c413d31ece7ca53836ad311c18d03b15331f08","claim":"Senti Biosciences, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-16 meeting.","evidence_excerpt":"2. Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstain 34,350,453 60,890 54,266","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"e7c88d8e0e9356c40f573a51555ee16d61274711","claim":"Senti Biosciences, Inc. shareholders approved Election of three Class I directors: Timothy Lu, M.D., Ph.D., Edward Mathers, and Omid Farokhzad, M.D. at the 2023-06-16 meeting.","evidence_excerpt":"1. Election of directors: Name For Withheld Broker Non-Votes Timothy Lu, M.D., Ph.D. 32,295,728 81,697 2,088,184 Edward Mathers 22,511,863 9,865,562 2,088,184 Omid Farokhzad, M.D. 26,184,748 6,192,677 2,088,184","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}